CN104606583A - Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease - Google Patents
Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease Download PDFInfo
- Publication number
- CN104606583A CN104606583A CN201510018170.7A CN201510018170A CN104606583A CN 104606583 A CN104606583 A CN 104606583A CN 201510018170 A CN201510018170 A CN 201510018170A CN 104606583 A CN104606583 A CN 104606583A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- rhizoma
- radix
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to traditional Chinese medicine composition for treating a chronic pelvic inflammatory disease. The traditional Chinese medicine composition comprises raw traditional Chinese medicines in parts by weight as follows: 5-20 parts of radix bupleuri, 5-25 parts of white paeony roots, 5-20 parts of radix scutellariae, 5-20 parts of cassis twigs, 5-25 parts of oyster, 5-20 parts of Chinese angelica, 5-20 parts of rhizoma chuanxiong, 5-25 parts of semen coicis, 5-20 parts of poria cocos, 5-20 parts of atractylodes macrocephala, 5-20 parts of moutan barks, 5-20 parts of edible tulip, 5-20 parts of rhizoma alismatis, 5-25 parts of trogopterus dung, 5-20 parts of rhizoma paridis, 5-20 parts of semen plantaginis, 5-25 parts of allium macrostemon, 10-30 parts of polygonum cuspidatum, 5-20 parts of roses and 5-10 parts of liquorice. The traditional Chinese medicine composition has the effects of liver soothing, depression relief, spleen strengthening, qi supplement, heat clearance, toxicity elimination, blood activation, stasis removal, cold elimination and pain alleviation, the curative effect on chronic pelvic inflammatory disease is remarkable, and the function is reliable.
Description
Technical field
The present invention relates to a kind of pharmaceutical product not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease.
Background technology
Chronic pelvic inflammatory disease refers to that female internal genital organs and connective tissue basin peritoneum around thereof are inflamed.Common sympton is lower abdominal pain, heating, vaginal secretions increase.Stomachache is persistence, movable or sexual intercourse postemphasis.Gynecologial examination can have lifting pain or uterus tenderness or attachment area tenderness, and body temperature is more than 38 sometimes, and erythrocyte sedimentation rate or C reactive protein raise, and transvaginal sonography display fallopian tube increases thick, hydrosalpinx, companion or do not accompany pelvic hydrops.Fallopian tube Ovarian Tumor.Chronic pelvic inflammatory disease is a difficult problem in gynecological's common disease, patient Chang Yin obstinate and very painful, from all causing very large burden mentally, economically, seriously endangers the health of numerous women.Current western medical treatment chronic pelvic inflammatory disease mainly uses antibiotic, hormone and physiotherapy, but curative effect is all not obvious, and life-time service antibiotic easily causes the various disadvantages such as fastbacteria generation and double infection.
Motherland's medical science thinks that chronic pelvic inflammatory disease belongs to Chinese medicine " leukorrheal diseases ", " infertile ", " dysmenorrhea ", " menoxenia ", “ mass in the abdomen ", the category such as " metrorrhagia "; what think primary disease is due to depression of liver-QI; for a long time and fire-transformation is recklessly acted; spleen channel retention of damp-heat in the interior; excessive skin and give birth to; accidental cause is held concurrently sense poison heresy, so that damp and hot fire-toxin accumulates long-pending skin and forms.
According to theory of Chinese medical science, for the pathogeny of chronic pelvic inflammatory disease, adopt the method for the treatment of of soothing liver-QI for relieving depression, invigorating the spleen and benefiting QI, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, dispersing cold for relieving pain, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome in prior art the deficiency for the treatment of chronic pelvic inflammatory disease and existing, the invention provides a kind of prepare easy, cost is low, evident in efficacy, the Chinese medicine composition for the treatment of chronic pelvic inflammatory disease that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, it is characterized in that: its raw material of Chinese medicine and weight are: Radix Bupleuri 5-20 part, Radix Paeoniae Alba 5-25 part, Radix Scutellariae 5-20 part, Ramulus Cinnamomi 5-20 part, Concha Ostreae 5-25 part, Radix Angelicae Sinensis 5-20 part, Rhizoma Chuanxiong 5-20 part, Semen Coicis 5-25 part, Poria 5-20 part, Rhizoma Atractylodis Macrocephalae 5-20 part, Cortex Moutan 5-20 part, Pseudobulbus cremastrae seu pleiones 5-20 part, Rhizoma Alismatis 5-20 part, Oletum Trogopterori 5-25 part, Rhizoma Paridis 5-20 part, Semen Plantaginis 5-20 part, Bulbus Allii Macrostemonis 5-25 part, Rhizoma Polygoni Cuspidati 10-30 part, Flos Rosae Rugosae 5-20 part, Radix Glycyrrhizae 5-10 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, is characterized in that: its raw material of Chinese medicine and weight are: Radix Bupleuri 10 parts, the Radix Paeoniae Alba 15 parts, Radix Scutellariae 10 parts, Ramulus Cinnamomi 10 parts, Concha Ostreae 15 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 10 parts, Semen Coicis 15 parts, 10 parts, Poria, the Rhizoma Atractylodis Macrocephalae 10 parts, Cortex Moutan 10 parts, Pseudobulbus cremastrae seu pleiones 10 parts, Rhizoma Alismatis 10 parts, Oletum Trogopterori 15 parts, Rhizoma Paridis 12 parts, Semen Plantaginis 10 parts, Bulbus Allii Macrostemonis 15 parts, Rhizoma Polygoni Cuspidati 20 parts, Flos Rosae Rugosae 10 parts, 6 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Radix Bupleuri have evacuate bring down a fever, effect of yang invigorating soothing liver-QI; The Radix Paeoniae Alba has effect of nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing receipts antiperspirant; Radix Scutellariae has effect of heat clearing and damp drying, eliminating fire and detoxication, arresting bleeding and miscarriage prevention; Ramulus Cinnamomi has effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Concha Ostreae has the astringent or styptic treatment for spontaneous sweating effect of suppressing the hyperactive liver and subsiding YANG, tranquillizing the mind by relieving convulsion, hard masses softening and resolving, convergence; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation; Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Semen Coicis has inducing diuresis to remove edema, spleen invigorating is dried, effect of arthralgia relieving by relaxing muscles and tendons, clearing away heat and discharging pus; Poria has effect of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming; The Rhizoma Atractylodis Macrocephalae has the antiabortive effect of invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis; Cortex Moutan has effect of clearing away heat and cooling blood, promoting blood circulation to remove blood stasis; Pseudobulbus cremastrae seu pleiones has dispersing swelling and dissipating binds, effect of removing toxic substances of reducing phlegm; Rhizoma Alismatis has promoting diuresis to eliminate damp pathogen, expel the heat-evil treating stranguria effect; Oletum Trogopterori has promoting blood circulation and stopping pain, effect of removing stasis to stop bleeding; Rhizoma Paridis has effect of heat-clearing and toxic substances removing, reducing swelling and alleviating pain, the arresting convulsion of cool liver; Semen Plantaginis has effect of relieving stranguria by diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, removing heat-phlegm; Bulbus Allii Macrostemonis has effect of activating YANG and eliminating stagnation, circulation of qi promoting intestinal stasis relieving, the chest stuffiness relieving of regulating the flow of vital energy; Rhizoma Polygoni Cuspidati has effect of promoting blood circulation to remove blood stasis, dispelling wind and removing obstruction in the collateral, clearing away heat-damp and promoting diuresis, removing toxic substances, relieving cough and resolving phlegm; Flos Rosae Rugosae has effect of promoting QI circulation for relieving depression, promoting blood flow to regulate menstruation; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component, through dialectical compatibility, helps using mutually assistant, plays effect of soothing liver-QI for relieving depression, invigorating the spleen and benefiting QI, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, dispersing cold for relieving pain altogether, reach treating both the principal and secondary aspects of a disease to the treatment of chronic pelvic inflammatory disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopts the use that is decocted in water for oral dose.Through clinical practice checking, it is reliably evident in efficacy, mild in medicine property and, do not occur toxic and side effects, effective percentage reaches 93%, cure rate 71%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, its raw material of Chinese medicine and weight proportion are: Radix Bupleuri 10g, Radix Paeoniae Alba 15g, Radix Scutellariae 10g, Ramulus Cinnamomi 10g, Concha Ostreae 15g, Radix Angelicae Sinensis 10g, Rhizoma Chuanxiong 10g, Semen Coicis 15g, Poria 10g, Rhizoma Atractylodis Macrocephalae 10g, Cortex Moutan 10g, Pseudobulbus cremastrae seu pleiones 10g, Rhizoma Alismatis 10g, Oletum Trogopterori 15g, Rhizoma Paridis 12g, Semen Plantaginis 10g, Bulbus Allii Macrostemonis 15g, Rhizoma Polygoni Cuspidati 20g, Flos Rosae Rugosae 10g, Radix Glycyrrhizae 6g.
Embodiment 2
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, its raw material of Chinese medicine and weight proportion are: Radix Bupleuri 15g, Radix Paeoniae Alba 25g, Radix Scutellariae 5g, Ramulus Cinnamomi 20g, Concha Ostreae 10g, Radix Angelicae Sinensis 20g, Rhizoma Chuanxiong 15g, Semen Coicis 5g, Poria 20g, Rhizoma Atractylodis Macrocephalae 15g, Cortex Moutan 5g, Pseudobulbus cremastrae seu pleiones 20g, Rhizoma Alismatis 15g, Oletum Trogopterori 25g, Rhizoma Paridis 5g, Semen Plantaginis 20g, Bulbus Allii Macrostemonis 10g, Rhizoma Polygoni Cuspidati 30g, Flos Rosae Rugosae 5g, Radix Glycyrrhizae 8g.
Embodiment 3
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, its raw material of Chinese medicine and weight proportion are: Radix Bupleuri 5g, Radix Paeoniae Alba 10g, Radix Scutellariae 20g, Ramulus Cinnamomi 12g, Concha Ostreae 5g, Radix Angelicae Sinensis 15g, Rhizoma Chuanxiong 12g, Semen Coicis 25g, Poria 15g, Rhizoma Atractylodis Macrocephalae 12g, Cortex Moutan 15g, Pseudobulbus cremastrae seu pleiones 12g, Rhizoma Alismatis 5g, Oletum Trogopterori 20g, Rhizoma Paridis 10g, Semen Plantaginis 15g, Bulbus Allii Macrostemonis 20g, Rhizoma Polygoni Cuspidati 5g, Flos Rosae Rugosae 15g, Radix Glycyrrhizae 9g.
Embodiment 4
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, its raw material of Chinese medicine and weight proportion are: Radix Bupleuri 12g, Radix Paeoniae Alba 20g, Radix Scutellariae 15g, Ramulus Cinnamomi 5g, Concha Ostreae 20g, Radix Angelicae Sinensis 12g, Rhizoma Chuanxiong 5g, Semen Coicis 20g, Poria 12g, Rhizoma Atractylodis Macrocephalae 5g, Cortex Moutan 20g, Pseudobulbus cremastrae seu pleiones 15g, Rhizoma Alismatis 12g, Oletum Trogopterori 5g, Rhizoma Paridis 15g, Semen Plantaginis 12g, Bulbus Allii Macrostemonis 5g, Rhizoma Polygoni Cuspidati 25g, Flos Rosae Rugosae 12g, Radix Glycyrrhizae 5g.
Embodiment 5
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, its raw material of Chinese medicine and weight proportion are: Radix Bupleuri 20g, Radix Paeoniae Alba 5g, Radix Scutellariae 12g, Ramulus Cinnamomi 15g, Concha Ostreae 25g, Radix Angelicae Sinensis 5g, Rhizoma Chuanxiong 20g, Semen Coicis 10g, Poria 5g, Rhizoma Atractylodis Macrocephalae 20g, Cortex Moutan 12g, Pseudobulbus cremastrae seu pleiones 5g, Rhizoma Alismatis 20g, Oletum Trogopterori 10g, Rhizoma Paridis 20g, Semen Plantaginis 5g, Bulbus Allii Macrostemonis 25g, Rhizoma Polygoni Cuspidati 15g, Flos Rosae Rugosae 20g, Radix Glycyrrhizae 10g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and covers powder, soaks 15 ~ 20 minutes, then adds water and do not have powder about 6 centimetres, carries out first time to decoct, and adopts intense fire to decoct, with slow fire boiling 20 ~ 30 minutes after boiling at a simmer; Second time decocts, and adds water and does not have powder about 4 centimetres, decocts 15 ~ 20 minutes after water boils.Decoct extracting juice twice, merge.
The present invention, with a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 100 example, 25 ~ 50 years old age.
Two, diagnosis basis:
Diagnostic criteria with reference to chronic pelvic inflammatory disease in " Chinese medical disease Standardization of diagnosis and curative effect " that State Administration of Traditional Chinese Medicine issues:
(1) lower abdomen and lumbago, lower abdomen falling inflation, lumbosacral region are ached, after fatigue of being everlasting, sexual intercourse, defecation time, increase the weight of before and after menstruation, can increase or leucorrhoea grow in quantity with low grade fever, menstruation;
(2) gynecologial examination: abdominal part has slight tenderness, can touch streak thing in side, uterus or bilateral during fallopian tube inflammation, and have tenderness, and during the inflammation of pelvic cavity connective tissue, side, uterus or bilateral have lamellar to thicken and tenderness;
(3) make a definite diagnosis prompting through ultrasonic, uterus heavy wall and pelvic cavity have hydrops, or have fallopian tube increase thick or have cystic enclosed mass etc.
Three, usage and dosage: during clinical practice, potion on the one, decocting twice extracting juice is about 400ml, point morning, late twice empty stomach decoction being taken warmly.It within six days, is a course for the treatment of.Treatments period is avoided cold and uncooked food the thing of pungent stimulation.
Four, criterion of therapeutical effect:
Criterion of therapeutical effect with reference to chronic pelvic inflammatory disease in " Chinese medical disease Standardization of diagnosis and curative effect ":
(1) cure: clinical symptoms, sign disappear, gynecological and ultrasonic examination report show no obvious abnormalities;
(2) effective: clinical symptoms, sign disappear, and gynecological and ultrasonic examination are significantly improved;
(3) effective: clinical symptoms, sign and gynecological and ultrasonic all have alleviate;
(4) invalid: clinical symptoms, sign and gynecological and ultrasonic examination are all without improvement.
Five, therapeutic effect: in this clinical observation case, takes medicine 2-5 the course for the treatment of, and recovery from illness 71 example, follows up a case by regular visits to and have no recurrence; Effective 14 examples, effective 8 examples, invalid 7 examples.There is not toxic and side effects in treatments period.
Six, model case:
Case 1:
Beam, 32 years old.Patient's readme: more than lower abdomen falling inflation pain half a year, time light time heavy, tenderness, soreness of the waist and knees, leucorrhea amount is many at ordinary times, dizzy weak, has stomachache when menstrual period and sexual intercourse.Gynecologial examination: lifting pain, vaginal secretions is many, uterus tenderness, and left side attachment district thickens tenderness.Be diagnosed as: chronic pelvic inflammatory disease.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, lower abdomen falling inflation pain disappears, and gynecologial examination lifting pain, uterus tenderness, left side attachment district thicken tenderness and all obviously alleviate; Continue to take 2 courses for the treatment of, all symptoms disappear completely, recovery from illness.Follow up a case by regular visits to after half a year without recurrence.
Case 2:
Liu, 25 years old.Conscious hypogastralgia the year before, leucorrhoea grow in quantity, menoxenia.Increase the weight of in the recent period, leucorrhea yellow skin amount is many, and stench is unpleasant, companion frequent micturition, urgent micturition.Examine and see: red tongue, thick, yellow and greasy fur, slippery and rapid pulse.Ultrasonic examination is pointed out: pelvic hydrops is a small amount of, is diagnosed as chronic pelvic inflammatory disease.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, hypogastralgia obviously alleviates, and all the other symptoms are also eased; Continue to take 2 courses for the treatment of, all symptoms disappear completely, recovery from illness.
Claims (2)
1. treat a Chinese medicine composition for chronic pelvic inflammatory disease, it is characterized in that: its raw material of Chinese medicine and weight are: Radix Bupleuri 5-20 part, Radix Paeoniae Alba 5-25 part, Radix Scutellariae 5-20 part, Ramulus Cinnamomi 5-20 part, Concha Ostreae 5-25 part, Radix Angelicae Sinensis 5-20 part, Rhizoma Chuanxiong 5-20 part, Semen Coicis 5-25 part, Poria 5-20 part, Rhizoma Atractylodis Macrocephalae 5-20 part, Cortex Moutan 5-20 part, Pseudobulbus cremastrae seu pleiones 5-20 part, Rhizoma Alismatis 5-20 part, Oletum Trogopterori 5-25 part, Rhizoma Paridis 5-20 part, Semen Plantaginis 5-20 part, Bulbus Allii Macrostemonis 5-25 part, Rhizoma Polygoni Cuspidati 10-30 part, Flos Rosae Rugosae 5-20 part, Radix Glycyrrhizae 5-10 part.
2. a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease according to claim 1, is characterized in that: its raw material of Chinese medicine and weight are: Radix Bupleuri 10 parts, the Radix Paeoniae Alba 15 parts, Radix Scutellariae 10 parts, Ramulus Cinnamomi 10 parts, Concha Ostreae 15 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 10 parts, Semen Coicis 15 parts, 10 parts, Poria, the Rhizoma Atractylodis Macrocephalae 10 parts, Cortex Moutan 10 parts, Pseudobulbus cremastrae seu pleiones 10 parts, Rhizoma Alismatis 10 parts, Oletum Trogopterori 15 parts, Rhizoma Paridis 12 parts, Semen Plantaginis 10 parts, Bulbus Allii Macrostemonis 15 parts, Rhizoma Polygoni Cuspidati 20 parts, Flos Rosae Rugosae 10 parts, 6 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510018170.7A CN104606583A (en) | 2015-01-15 | 2015-01-15 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510018170.7A CN104606583A (en) | 2015-01-15 | 2015-01-15 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104606583A true CN104606583A (en) | 2015-05-13 |
Family
ID=53141404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510018170.7A Pending CN104606583A (en) | 2015-01-15 | 2015-01-15 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104606583A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686407A (en) * | 2005-04-19 | 2005-10-26 | 王福斗 | Gynecopathy convalescence powder |
| CN103393989A (en) * | 2013-07-24 | 2013-11-20 | 赵世明 | Traditional Chinese medicine composition for treating gynecologic inflammation |
-
2015
- 2015-01-15 CN CN201510018170.7A patent/CN104606583A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686407A (en) * | 2005-04-19 | 2005-10-26 | 王福斗 | Gynecopathy convalescence powder |
| CN103393989A (en) * | 2013-07-24 | 2013-11-20 | 赵世明 | Traditional Chinese medicine composition for treating gynecologic inflammation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007191B (en) | Chinese medicinal composition for treating jaundice | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN102423366A (en) | Chinese medicinal composition for treating metrorrhagia and metrostaxis | |
| CN103705902A (en) | Traditional Chinese medicine composition for treating postpartum lochiorrhea | |
| CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
| CN103393989B (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
| CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
| CN104173856A (en) | Traditional Chinese medicine composition for treating morbid leukorrhea | |
| CN103251889A (en) | Traditional Chinese medicine composition for treating agalactia | |
| CN103041301A (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN103127427B (en) | Chinese medicinal composition for treating chronic pelvic inflammation | |
| CN104013765A (en) | Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin | |
| CN104606583A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease | |
| CN105770374A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
| CN105687909A (en) | Traditional Chinese medicine composition for treating dysuria | |
| CN105943989A (en) | Traditional Chinese medicine composition for treating nonliquefaction of semen | |
| CN103720986A (en) | Traditional Chinese medicine composition for treating leukorrhea | |
| CN105560994A (en) | Traditional Chinese medicine composition for treating prolapse of uterus | |
| CN105079327A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN105288332A (en) | Traditional Chinese medicine composition for treating cyesedema | |
| CN104587256A (en) | Traditional Chinese medicine composition for treating prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150513 |
|
| RJ01 | Rejection of invention patent application after publication |